Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Vagner Danielsen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Plos One|June 28, 2022
Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity?Puria Nabilou, Karen Vagner Danielsen, Nina Kimer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 30, 2023
Effect of beta-blockers on multiple haemodynamics in cirrhosis: A cross-over study by MR-imaging and hepatic vein catheterizationKaren Vagner Danielsen, Puria Nabilou, Signe Skovgaard Wiese, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2021
Patients With Cirrhosis Have Elevated Bone Turnover but Normal Hepatic Production of OsteoprotegerinNiklas Rye Jørgensen, Sarah Seberg Diemar, Gitte Lund Christensen, et al.
Ugeskrift for Laeger|February 26, 2019
[Magnetic resonance imaging for the diagnosis of non-alcoholic fatty liver disease]Ditte Marie Kirkegaard-Klitbo, Karen Vagner Danielsen, Lars G Hanson, et al.
The American Journal of Gastroenterology|August 2, 2022
Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance StudyKaren Vagner Danielsen, Signe Wiese, Troels Busk, et al.
World Journal of Clinical Cases|May 21, 2020
Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literatureElias Badal Rashu, Anders Ellekær Junker, Karen Vagner Danielsen, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2025
Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imagingKaren Vagner Danielsen, Jens Dahlgaard Hove, Puria Nabilou, et al.
Scientific Reports|November 17, 2023
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry studyThit Mynster Kronborg, Henry Webel, Malene Barfod O'Connell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 1, 2021
Using MR elastography to assess portal hypertension and response to beta-blockers in patients with cirrhosisKaren Vagner Danielsen, Jens Dahlgaard Hove, Puria Nabilou, et al.
Journal of Hepatology|November 23, 2020
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosisJonel Trebicka, Javier Fernandez, Maria Papp, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Plos One|June 28, 2022
Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity?Puria Nabilou, Karen Vagner Danielsen, Nina Kimer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 30, 2023
Effect of beta-blockers on multiple haemodynamics in cirrhosis: A cross-over study by MR-imaging and hepatic vein catheterizationKaren Vagner Danielsen, Puria Nabilou, Signe Skovgaard Wiese, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2021
Patients With Cirrhosis Have Elevated Bone Turnover but Normal Hepatic Production of OsteoprotegerinNiklas Rye Jørgensen, Sarah Seberg Diemar, Gitte Lund Christensen, et al.
Ugeskrift for Laeger|February 26, 2019
[Magnetic resonance imaging for the diagnosis of non-alcoholic fatty liver disease]Ditte Marie Kirkegaard-Klitbo, Karen Vagner Danielsen, Lars G Hanson, et al.
The American Journal of Gastroenterology|August 2, 2022
Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance StudyKaren Vagner Danielsen, Signe Wiese, Troels Busk, et al.
World Journal of Clinical Cases|May 21, 2020
Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literatureElias Badal Rashu, Anders Ellekær Junker, Karen Vagner Danielsen, et al.
JHEP Reports : Innovation in Hepatology|July 18, 2025
Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imagingKaren Vagner Danielsen, Jens Dahlgaard Hove, Puria Nabilou, et al.
Scientific Reports|November 17, 2023
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry studyThit Mynster Kronborg, Henry Webel, Malene Barfod O'Connell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 1, 2021
Using MR elastography to assess portal hypertension and response to beta-blockers in patients with cirrhosisKaren Vagner Danielsen, Jens Dahlgaard Hove, Puria Nabilou, et al.
Journal of Hepatology|November 23, 2020
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosisJonel Trebicka, Javier Fernandez, Maria Papp, et al.
Pageof 2